Title | Emergence of resistance to tyrosine kinase inhibitors in non-small cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib |
Study Type | Other |
Abstract | Targeted exome sequencing of crizotinib-sensitive control cell line (H2228-CS) and crizotinib-resistant cell lines (H2228-CR). |
Description | Targeted exome sequencing of crizotinib-sensitive control cell line (H2228-CS) and crizotinib-resistant cell lines (H2228-CR). |
Center Name | Astex Pharmaceuticals |
Url Link | E-MTAB-4851 in ArrayExpress |
![]() |
Submission | ERA673596 |
![]() |
|
![]() |
Experiment | ERX1589911 |
![]() |
![]() |
ERX1589912 |
![]() |
![]() |
||
ERX1589913 |
![]() |
![]() |
||
ERX1589914 |
![]() |
![]() |
||
ERX1589915 |
![]() |
![]() |
||
ERX1589916 |
![]() |
![]() |
||
ERX1589917 |
![]() |
![]() |
||
![]() |
Sample | ERS1237150 | ||
ERS1237151 | ||||
ERS1237152 | ||||
ERS1237153 | ||||
ERS1237154 | ||||
ERS1237155 | ||||
ERS1237156 |